Patients taking Kerendia saw significant reduction in cardiovascular death and hospitalization and urgent visits for heart ...

The FDA expanded the indication for finerenone (Kerendia) in heart failure (HF), drug manufacturer Bayer announced.

Following priority review, the U.S. Food and Drug Administration approved Bayer's Kerendia (finerenone) for the treatment of ...

Heart failure, a condition where the heart doesn't pump blood efficiently, manifests through symptoms like shortness of ...

The use of SGLT2 inhibitors has been a game-changer in the treatment of heart failure (HF). Now, another drug class has ...

Wearables and telehealth are teaming up to transform chronic care. This connected model offers real-time data for proactive, ...

Scientists have discovered that four health habits — which include sleep quality and nicotine use — were the most important ...

Kerendia was originally approved in July 2021 to reduce cardiovascular and kidney complications in patients with chronic ...

Warning signs of an unhealthy heart, though, can lurk — not so quietly — in its many complex sounds. That's why FIU researchers Joshua Hutcheson and Valentina Dargam have come up with a way to "listen ...

Heart failure, a leading cause of death in the US, can be triggered by cardiac amyloidosis, a condition often misdiagnosed as ...

Researchers found an 11% higher risk for cardiovascular disease in women diagnosed with severe symptoms, not just mild or ...

Discover how MemorialCare's Women's Heart Center at Long Beach is tackling the leading killer of women, heart disease, ...